| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eicosanoids | 15 | 2023 | 282 | 4.930 |
Why?
|
| Epoxide Hydrolases | 13 | 2024 | 122 | 3.310 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2018 | 1496 | 1.320 |
Why?
|
| Neoplasms | 22 | 2024 | 22173 | 1.270 |
Why?
|
| Inflammation | 16 | 2024 | 10774 | 1.090 |
Why?
|
| Neoplasms, Experimental | 6 | 2019 | 1229 | 1.060 |
Why?
|
| Neoplasm Metastasis | 8 | 2021 | 4915 | 0.980 |
Why?
|
| Docosahexaenoic Acids | 5 | 2019 | 907 | 0.960 |
Why?
|
| Neovascularization, Pathologic | 18 | 2023 | 2645 | 0.950 |
Why?
|
| Cyclooxygenase 2 | 5 | 2023 | 597 | 0.940 |
Why?
|
| Prostaglandins | 3 | 2023 | 398 | 0.890 |
Why?
|
| Electrocardiography | 4 | 2018 | 6377 | 0.870 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2023 | 44 | 0.830 |
Why?
|
| Antineoplastic Agents | 12 | 2021 | 13642 | 0.810 |
Why?
|
| Liver Regeneration | 2 | 2014 | 213 | 0.800 |
Why?
|
| Cytokines | 9 | 2021 | 7396 | 0.790 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2023 | 321 | 0.780 |
Why?
|
| Lipid Metabolism | 4 | 2018 | 1902 | 0.710 |
Why?
|
| Macrophages | 9 | 2022 | 5767 | 0.670 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 3 | 2017 | 64 | 0.660 |
Why?
|
| Fatty Acids | 2 | 2024 | 1808 | 0.650 |
Why?
|
| Ketorolac | 1 | 2019 | 94 | 0.630 |
Why?
|
| Epoxy Compounds | 3 | 2013 | 137 | 0.620 |
Why?
|
| Thromboxane A2 | 1 | 2018 | 88 | 0.620 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2019 | 540 | 0.600 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2011 | 412 | 0.550 |
Why?
|
| Neovascularization, Physiologic | 3 | 2014 | 1349 | 0.550 |
Why?
|
| Osteopontin | 1 | 2018 | 301 | 0.540 |
Why?
|
| PPAR alpha | 2 | 2008 | 175 | 0.530 |
Why?
|
| Angiogenesis Inhibitors | 10 | 2011 | 2048 | 0.480 |
Why?
|
| Cardiotonic Agents | 1 | 2017 | 539 | 0.460 |
Why?
|
| Neuropilin-1 | 1 | 2014 | 90 | 0.460 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2014 | 92 | 0.450 |
Why?
|
| Lipids | 3 | 2023 | 3341 | 0.450 |
Why?
|
| Tumor Microenvironment | 6 | 2024 | 3878 | 0.450 |
Why?
|
| Animals | 53 | 2024 | 168475 | 0.440 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1560 | 0.430 |
Why?
|
| Fluorouracil | 1 | 2018 | 1642 | 0.430 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2014 | 1390 | 0.420 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.410 |
Why?
|
| Wound Healing | 2 | 2014 | 2805 | 0.410 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3206 | 0.400 |
Why?
|
| Algorithms | 3 | 2018 | 14033 | 0.400 |
Why?
|
| Mice | 39 | 2024 | 81539 | 0.400 |
Why?
|
| Aflatoxin B1 | 2 | 2022 | 17 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2273 | 0.400 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 2024 | 0.380 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 4878 | 0.380 |
Why?
|
| Epidermis | 1 | 2014 | 528 | 0.370 |
Why?
|
| Inflammation Mediators | 4 | 2023 | 1886 | 0.370 |
Why?
|
| Databases as Topic | 3 | 2018 | 473 | 0.370 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1809 | 0.360 |
Why?
|
| Carcinoma, Lewis Lung | 5 | 2013 | 108 | 0.360 |
Why?
|
| Preoperative Care | 1 | 2019 | 2242 | 0.350 |
Why?
|
| Keratinocytes | 1 | 2014 | 791 | 0.350 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 379 | 0.340 |
Why?
|
| Phagocytosis | 3 | 2021 | 1528 | 0.330 |
Why?
|
| Fetus | 1 | 2017 | 1863 | 0.330 |
Why?
|
| Colonic Neoplasms | 2 | 2018 | 2539 | 0.330 |
Why?
|
| Bone Remodeling | 1 | 2013 | 581 | 0.330 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2016 | 2244 | 0.320 |
Why?
|
| Arachidonic Acid | 7 | 2023 | 427 | 0.320 |
Why?
|
| Glioma | 2 | 2022 | 3455 | 0.320 |
Why?
|
| Glioblastoma | 2 | 2022 | 3483 | 0.320 |
Why?
|
| Melanoma, Experimental | 4 | 2017 | 561 | 0.310 |
Why?
|
| Cell Proliferation | 9 | 2022 | 10451 | 0.310 |
Why?
|
| Carcinogens | 2 | 2020 | 452 | 0.300 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4317 | 0.300 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1779 | 0.300 |
Why?
|
| Pediatrics | 2 | 2020 | 3589 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2013 | 2827 | 0.290 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3060 | 0.290 |
Why?
|
| Fenofibrate | 1 | 2008 | 87 | 0.290 |
Why?
|
| Blood Platelets | 1 | 2018 | 2479 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 17 | 2021 | 22174 | 0.290 |
Why?
|
| Signal Transduction | 10 | 2022 | 23447 | 0.290 |
Why?
|
| Aspirin | 1 | 2019 | 3133 | 0.280 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3407 | 0.280 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2811 | 0.280 |
Why?
|
| Cell Line, Tumor | 8 | 2022 | 16990 | 0.280 |
Why?
|
| Endothelial Cells | 5 | 2014 | 3549 | 0.270 |
Why?
|
| Humans | 56 | 2024 | 761596 | 0.260 |
Why?
|
| Thiazoles | 2 | 2003 | 1517 | 0.250 |
Why?
|
| MicroRNAs | 1 | 2021 | 3816 | 0.250 |
Why?
|
| Granulocytes | 1 | 2007 | 551 | 0.240 |
Why?
|
| Regeneration | 1 | 2013 | 1512 | 0.230 |
Why?
|
| Heart Rate | 1 | 2015 | 4195 | 0.230 |
Why?
|
| Cell Movement | 3 | 2015 | 5205 | 0.220 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 9542 | 0.210 |
Why?
|
| Brain Neoplasms | 2 | 2022 | 9032 | 0.210 |
Why?
|
| PPAR gamma | 1 | 2005 | 484 | 0.200 |
Why?
|
| Pain | 1 | 2017 | 5073 | 0.200 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2014 | 244 | 0.190 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10194 | 0.190 |
Why?
|
| Liver | 2 | 2014 | 7528 | 0.190 |
Why?
|
| Cell Death | 3 | 2022 | 1679 | 0.190 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14417 | 0.190 |
Why?
|
| Hypertension | 2 | 2020 | 8540 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9280 | 0.180 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 2008 | 592 | 0.180 |
Why?
|
| Neoplastic Processes | 1 | 2020 | 35 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2018 | 3605 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 2492 | 0.180 |
Why?
|
| Stem Cells | 1 | 2013 | 3524 | 0.170 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3617 | 0.170 |
Why?
|
| Plasminogen Inactivators | 1 | 2019 | 37 | 0.170 |
Why?
|
| Thiazolidinediones | 1 | 2002 | 461 | 0.160 |
Why?
|
| Biology | 1 | 2021 | 290 | 0.160 |
Why?
|
| Sesquiterpenes | 5 | 2010 | 176 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2014 | 3492 | 0.150 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 331 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 2297 | 0.150 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 18255 | 0.150 |
Why?
|
| Neuroblastoma | 2 | 2020 | 1250 | 0.150 |
Why?
|
| Mice, SCID | 4 | 2019 | 2626 | 0.150 |
Why?
|
| Disease Progression | 4 | 2020 | 13510 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 858 | 0.150 |
Why?
|
| Platinum | 1 | 2019 | 220 | 0.140 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 652 | 0.140 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 3 | 2014 | 318 | 0.140 |
Why?
|
| Phenylurea Compounds | 1 | 2020 | 529 | 0.140 |
Why?
|
| Cyclooxygenase 1 | 1 | 2017 | 97 | 0.140 |
Why?
|
| Fuzzy Logic | 1 | 2017 | 57 | 0.140 |
Why?
|
| Pandemics | 3 | 2022 | 8656 | 0.140 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 188 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 605 | 0.130 |
Why?
|
| Receptor, TIE-2 | 2 | 2014 | 176 | 0.130 |
Why?
|
| Cyclohexanes | 5 | 2010 | 152 | 0.130 |
Why?
|
| Lipoxins | 1 | 2019 | 419 | 0.130 |
Why?
|
| Normal Distribution | 1 | 2016 | 272 | 0.130 |
Why?
|
| Lipoxygenases | 2 | 2014 | 13 | 0.130 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2016 | 134 | 0.130 |
Why?
|
| Taxoids | 1 | 2019 | 668 | 0.120 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 278 | 0.120 |
Why?
|
| Chemokines | 1 | 2019 | 959 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2018 | 646 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3597 | 0.120 |
Why?
|
| Ischemia | 1 | 2023 | 1884 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1351 | 0.110 |
Why?
|
| Tumor Burden | 2 | 2017 | 1892 | 0.110 |
Why?
|
| Apoptosis | 3 | 2020 | 9490 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2016 | 592 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1076 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 1023 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 4 | 2018 | 6131 | 0.110 |
Why?
|
| Organotechnetium Compounds | 1 | 2013 | 129 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 1058 | 0.110 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 225 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3076 | 0.100 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2013 | 105 | 0.100 |
Why?
|
| Medicine | 1 | 2021 | 942 | 0.100 |
Why?
|
| Blotting, Northern | 1 | 2014 | 1545 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 11076 | 0.100 |
Why?
|
| Endothelium, Vascular | 5 | 2012 | 4431 | 0.100 |
Why?
|
| Receptors, Eicosanoid | 1 | 2011 | 12 | 0.100 |
Why?
|
| Piperidines | 1 | 2020 | 1656 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1787 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 178 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 916 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 1914 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2017 | 1567 | 0.090 |
Why?
|
| Epithelium | 1 | 2016 | 1603 | 0.090 |
Why?
|
| Cell Line | 4 | 2020 | 15601 | 0.090 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 392 | 0.090 |
Why?
|
| Retinal Neovascularization | 1 | 2014 | 288 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 983 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 596 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2014 | 1900 | 0.090 |
Why?
|
| Colon | 1 | 2018 | 1792 | 0.090 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 224 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6214 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 3713 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 250 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2014 | 5035 | 0.080 |
Why?
|
| Colitis | 1 | 2018 | 1233 | 0.080 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 983 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2022 | 2017 | 0.080 |
Why?
|
| Metabolomics | 1 | 2019 | 1659 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2017 | 2767 | 0.080 |
Why?
|
| Eye | 1 | 2013 | 712 | 0.080 |
Why?
|
| Artifacts | 1 | 2018 | 1911 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2139 | 0.080 |
Why?
|
| Male | 20 | 2021 | 360846 | 0.080 |
Why?
|
| Ligands | 2 | 2008 | 3272 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 1068 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.080 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 8002 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2024 | 4652 | 0.080 |
Why?
|
| Fish Oils | 1 | 2011 | 483 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 1924 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1896 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1927 | 0.070 |
Why?
|
| Collagen | 3 | 2013 | 2638 | 0.070 |
Why?
|
| Sucrose | 1 | 2008 | 158 | 0.070 |
Why?
|
| Radiation Chimera | 1 | 2007 | 216 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1188 | 0.070 |
Why?
|
| Polymers | 1 | 2014 | 1616 | 0.070 |
Why?
|
| Cattle | 5 | 2008 | 3849 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 789 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4415 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2050 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 866 | 0.060 |
Why?
|
| RNA Interference | 1 | 2014 | 2832 | 0.060 |
Why?
|
| Pyrroles | 1 | 2011 | 1125 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 257 | 0.060 |
Why?
|
| Endothelium | 1 | 2008 | 765 | 0.060 |
Why?
|
| Corneal Neovascularization | 1 | 2007 | 185 | 0.060 |
Why?
|
| Survival Rate | 2 | 2018 | 12723 | 0.060 |
Why?
|
| Base Sequence | 2 | 2014 | 12441 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3430 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2020 | 8481 | 0.060 |
Why?
|
| Monocytes | 1 | 2014 | 2570 | 0.060 |
Why?
|
| Cell Division | 5 | 2008 | 4465 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 17635 | 0.060 |
Why?
|
| Zebrafish | 1 | 2015 | 3008 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5368 | 0.060 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2023 | 48 | 0.060 |
Why?
|
| Cornea | 3 | 2008 | 1333 | 0.060 |
Why?
|
| Indoles | 1 | 2011 | 1833 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6534 | 0.050 |
Why?
|
| Macular Degeneration | 1 | 2010 | 1007 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 3397 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2002 | 12130 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2014 | 1958 | 0.050 |
Why?
|
| Leukotrienes | 1 | 2023 | 231 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2017 | 1757 | 0.050 |
Why?
|
| Endothelial Growth Factors | 2 | 2001 | 673 | 0.050 |
Why?
|
| Organic Chemicals | 1 | 2002 | 210 | 0.050 |
Why?
|
| Child | 2 | 2020 | 80158 | 0.050 |
Why?
|
| Kidney | 2 | 2015 | 7048 | 0.050 |
Why?
|
| Cytochalasins | 1 | 2000 | 19 | 0.050 |
Why?
|
| Lymphokines | 2 | 2001 | 927 | 0.050 |
Why?
|
| Female | 8 | 2019 | 392705 | 0.050 |
Why?
|
| Glomerular Mesangium | 1 | 2020 | 98 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2023 | 597 | 0.040 |
Why?
|
| Granuloma | 1 | 2022 | 328 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 4024 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 719 | 0.040 |
Why?
|
| Diet | 2 | 2022 | 8075 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2016 | 11530 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 2417 | 0.040 |
Why?
|
| Sulindac | 1 | 1999 | 29 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 2693 | 0.040 |
Why?
|
| Lung | 2 | 2016 | 10002 | 0.040 |
Why?
|
| Enalapril | 1 | 2020 | 312 | 0.040 |
Why?
|
| Rats | 2 | 2011 | 23741 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 1768 | 0.040 |
Why?
|
| Triclosan | 1 | 2018 | 58 | 0.040 |
Why?
|
| Thrombopoietin | 1 | 1999 | 226 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 29629 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2000 | 2223 | 0.040 |
Why?
|
| Thalidomide | 2 | 2002 | 885 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2018 | 256 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 1999 | 292 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5672 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2016 | 12794 | 0.030 |
Why?
|
| Immunity | 1 | 2022 | 996 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2004 | 954 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5821 | 0.030 |
Why?
|
| Biological Transport | 2 | 2013 | 2091 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 13381 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 411 | 0.030 |
Why?
|
| Superoxides | 1 | 2017 | 387 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 379 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5672 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 29890 | 0.030 |
Why?
|
| Cytochromes | 1 | 2014 | 18 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 1091 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10766 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 579 | 0.030 |
Why?
|
| Hemangioma | 1 | 1999 | 727 | 0.030 |
Why?
|
| Lipoxygenase | 1 | 2014 | 72 | 0.030 |
Why?
|
| Biotransformation | 1 | 2014 | 166 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 1189 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 1459 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 321 | 0.030 |
Why?
|
| Penicillamine | 1 | 2013 | 60 | 0.030 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2000 | 783 | 0.030 |
Why?
|
| Intestines | 1 | 2022 | 1910 | 0.030 |
Why?
|
| Oxygen | 2 | 2016 | 4227 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1516 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 730 | 0.030 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2013 | 55 | 0.030 |
Why?
|
| Androgens | 1 | 2001 | 1286 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 2049 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3614 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 359 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 1687 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4576 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1999 | 1182 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 657 | 0.020 |
Why?
|
| Angiostatins | 2 | 2002 | 64 | 0.020 |
Why?
|
| Metabolome | 1 | 2018 | 989 | 0.020 |
Why?
|
| Plasminogen | 2 | 2002 | 144 | 0.020 |
Why?
|
| Endostatins | 2 | 2002 | 168 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2002 | 3313 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2014 | 633 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 791 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2010 | 426 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 253 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2014 | 561 | 0.020 |
Why?
|
| Integrases | 1 | 2012 | 518 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4580 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1835 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 748 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2206 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 1157 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2000 | 1085 | 0.020 |
Why?
|
| Kinetics | 2 | 2010 | 6374 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 1674 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 871 | 0.020 |
Why?
|
| Microscopy | 1 | 2013 | 903 | 0.020 |
Why?
|
| Descemet Membrane | 1 | 2008 | 71 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 687 | 0.020 |
Why?
|
| Microvessels | 1 | 2011 | 577 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 4125 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2016 | 4160 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2014 | 1995 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 2865 | 0.020 |
Why?
|
| Microcirculation | 1 | 2010 | 1272 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1334 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 3733 | 0.020 |
Why?
|
| Capillaries | 1 | 2008 | 755 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 1935 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3792 | 0.010 |
Why?
|
| Centrosome | 1 | 2004 | 209 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2057 | 0.010 |
Why?
|
| Models, Biological | 1 | 1999 | 9469 | 0.010 |
Why?
|
| Karyotyping | 1 | 2004 | 1171 | 0.010 |
Why?
|
| Phenylbutyrates | 1 | 2002 | 72 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2008 | 1154 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7593 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2004 | 552 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.010 |
Why?
|
| Mycotoxins | 1 | 2000 | 35 | 0.010 |
Why?
|
| Aspergillus | 1 | 2000 | 93 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2004 | 727 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 2820 | 0.010 |
Why?
|
| Aminopeptidases | 1 | 2000 | 95 | 0.010 |
Why?
|
| Obesity | 1 | 2002 | 12947 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1999 | 306 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1999 | 413 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13446 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 393 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 2510 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 1330 | 0.010 |
Why?
|
| Mitochondria | 1 | 2011 | 3624 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2002 | 5112 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 522 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9353 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 11122 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2000 | 718 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2002 | 1007 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11904 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8554 | 0.010 |
Why?
|
| Platelet Count | 1 | 1999 | 781 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 39969 | 0.010 |
Why?
|
| Syndrome | 1 | 1999 | 3267 | 0.010 |
Why?
|
| Body Composition | 1 | 2002 | 2426 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 4772 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18966 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 4618 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2002 | 2882 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1999 | 4021 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 27121 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 220921 | 0.000 |
Why?
|